Low Tidal Volume Ventilation With Hyperoxia Avoidance During Cardiopulmonary Bypass (The FOCUS Trial) | MicrobiomeTrials← Back to trialsNCT04978636
Low Tidal Volume Ventilation With Hyperoxia Avoidance During Cardiopulmonary Bypass (The FOCUS Trial)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2021-09-20Est. Completion: 2026-12-31
Enrollment target: 5,502 participants Locations- Cleveland Clinic Foundation, Cleveland, Ohio, United States
Other microbiome trials you might be interested in
Coronary Artery Bypass Graft Surgery(CABG)Postoperative Pain Management
The purpose of this randomized controlled clinical trial was to investigate whether virtual reality (VR) could reduce pa…
Istanbul, Turkey (Türkiye)Completed Jan 5, 2026
Ventricular Arrhythmia
Background:
Ventricular arrhythmia is an abnormal pulse rhythm that starts in the lower part of the heart (ventricles).…
Atlanta, United StatesCompleted Dec 1, 2026
Transcatheter aortic valve implantation (TAVI) is a key-hole technique to replace an aortic heart valve that is narrowed…
Aarhus, DenmarkEst. completion Dec 2027